The Pulse
Nolla Health’s AI Writes Initial Acne Prescriptions in Utah
Nolla Health says Utah residents 18 and older can use its app for AI-issued initial acne prescriptions, with the state’s authorized-pilots listing marking the program active from October 5, 2026, through October 5, 2027. The pilot is limite
AI.info Team · Written with AI ·
Nolla Health says its AI can issue an initial acne prescription in minutes for $4.99 a month, without requiring a patient to have an existing prescription. The company announced the Utah launch on October 5, 2026, through its Nolla Derm app, calling it the first U.S. program in which AI can issue initial prescriptions. Utah’s published rules limit what the system can prescribe, and the state’s authorized-pilots listing marks Nolla’s pilot active for a one-year term.
Utah’s approval covers a narrow set of topical treatments
The state authorized Nolla Health to issue first-time prescriptions and refills for topical acne medicines to Utah adults with mild or moderate acne. The system assesses photographs of a patient’s face and can choose only from a short list of creams and gels specified in its agreement. It cannot prescribe oral medication or isotretinoin, and patients with severe acne are outside the pilot.
The agreement also excludes people who are pregnant or planning to become pregnant, breastfeeding, immunocompromised, or who have previously reacted to a listed medication. Nolla must verify a patient’s identity and age with government photo identification, and prescriptions can go only to Utah addresses. The state’s authorized-pilots listing says the Utah Division of Professional Licensing agreed not to enforce specified licensing and telehealth provisions when the company follows the approved protocol; the relief applies only to that defined service.
Doctors review every prescription at first
Utah’s rules require two Utah-licensed physicians to review each prescription before it reaches a patient in the initial phase. Later phases shift to review after prescriptions are issued and then to sampling, but each step requires written state approval. Pharmacists must be told that a prescription came from AI and given a physician to contact with questions.
Nolla’s announcement describes physician oversight in three stages: review before delivery for the first 100 patients, daily retrospective review during the next stage, and weekly sampling afterward. The company says patients who fall outside the system’s confidence threshold go to a licensed physician instead. Its app also offers messaging with a licensed physician, and the company says patients reaching out for support are not speaking with AI.
The state listing marks the pilot active
Nolla’s announcement says Utah residents aged 18 and older can sign up, and its pilot page advertises the service as available. The Utah Department of Commerce lists Nolla Health’s pilot as active, with a term from October 5, 2026, through October 5, 2027. The agreement was signed September 22, 2026, and co-signed with the Division of Professional Licensing.
The company prices the pilot at $4.99 per month. Nolla says users complete a 10-to-15-minute questionnaire and face scan before receiving a treatment plan, and that prescriptions can be delivered to a home or sent to a pharmacy for pickup. The app also uses daily scans to track skin changes; Nolla says it reviews treatment plans every 28 scans on its pilot page.
“The real test” is whether the state can stop it
Nolla co-founder and chief executive Luis Wenus framed the program as an access measure.
“AI will matter most in healthcare when it helps people get care they otherwise would not receive,” said Luis Wenus, co-founder and CEO of Nolla Health.
The release cites long waits for dermatology appointments in Utah and argues that routine acne cases could be handled without taking clinician time away from more complex care.
The state’s safeguards require Nolla to report adverse events within 24 hours and submit monthly information that includes how often physicians agree with the AI’s decisions. The agreement also requires professional liability insurance and bars the sale or transfer of patient data. The pilot is not a general authorization for AI to practice medicine: it applies to one company, one limited treatment area and a phased review process whose next steps remain subject to state approval.